Sanofi traded at $50.18 this Tuesday July 5th, decreasing $0.83 or 1.63 percent since the previous trading session. Looking back, over the last four weeks, Sanofi lost 5.68 percent. Over the last 12 months, its price fell by 2.43 percent. Looking ahead, we forecast Sanofi to be priced at 49.18 by the end of this quarter and at 44.07 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
50.18
Daily Change
-1.63%
Yearly
-2.43%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
AbbVie 153.94 0.14 0.09% 33.02%
Amgen 246.73 1.18 0.48% 1.26%
AstraZeneca 10,800.00 -8.00 -0.07% 23.84%
Astrazeneca 65.51 -0.44 -0.67% 9.37%
Bristol-Myers Squibb 75.96 -0.88 -1.15% 13.97%
Corcept Therapeutics 25.73 0.29 1.14% 16.58%
Catalent 105.99 -1.03 -0.96% -6.33%
Endo International 0.52 -0.05 -8.79% -88.21%
Genmab 2,407.00 54.00 2.29% -8.41%
Galapagos 54.90 1.84 3.47% -5.08%
GlaxoSmithKline 1,786.60 -16.00 -0.89% 24.57%
Glaxosmithkline 43.30 -0.45 -1.03% 8.09%
Horizon Pharma 82.76 1.92 2.38% -13.59%
Jazz Pharmaceuticals 160.04 1.46 0.92% -12.51%
J&J 178.00 -1.52 -0.85% 5.97%
Lannett 0.58 0.02 2.73% -87.41%
Eli Lilly 327.18 2.47 0.76% 38.98%
Merck & Co 92.64 0.22 0.24% 18.60%
Novartis 80.91 -0.74 -0.91% -4.31%
Novartis 84.28 -0.08 -0.09% -7.97%
Phibro Animal Health 20.15 0.56 2.86% -29.99%
Prestige Brands 59.78 0.20 0.34% 15.43%
Pacira 58.35 0.50 0.86% 1.23%
Pfizer 51.64 -0.67 -1.28% 31.43%
Powershares High Yield Orate Bond Portfolio 17.01 0.02 0.12% -13.26%
Perrigo 40.80 -0.22 -0.54% -13.01%
Drreddys Laboratories 55.87 0.03 0.05% -24.86%
Roche Holding 319.00 -3.60 -1.12% -9.76%
Supernus Pharmaceuticals 29.80 0.45 1.53% -0.96%
Teva Pharmaceutical Industries 7.71 -0.18 -2.28% -19.77%
UCB 82.60 -0.04 -0.05% -6.92%
United States Oil Fund 74.78 -6.89 -8.44% 49.86%
Canopy Growth Corp 3.52 -0.11 -3.03% -87.66%
Zoetis 174.25 0.04 0.02% -10.19%


Sanofi
Sanofi SA is a healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme, among others.